Part of ANZGOG’s OASIS initiative, the IGNITE clinical trial seeks to obtain important clinical data on high-grade serous ovarian cancer treatment.
Dr. George Au-Yeung is a medical oncologist at the Peter MacCallum Cancer Center
IGNITE is a phase II trial, testing whether the use of adavosertib will provide clinical benefit to women with recurrent high-grade serous ovarian cancer.
The study is seeking 64 participants at ten sites across Australia. Women aged over 18 and have platinum resistant high grade serous ovarian cancer with Cyclin E1 over-expression are encouraged to speak to their medical oncologist about their eligibility.
The IGNITE trial is currently recruiting from the following sites:
- Peter MacCallum Cancer Centre – Melbourne, VIC
- Sir Charles Gairdner Hospital – Nedlands, WA
- Prince of Wales Hospital – Randwick, NSW
- Westmead Hospital – Westmead, NSW
- Orange Health Service – Orange, NSW
- Sunshine Hospital – St Albans, VIC
- Flinders Medical Centre – Bedford Park, SA
- Royal North Shore Hospital – Sydney, NSW
If you believe that you may be a suitable candidate, please speak to your Medical Oncologist about your eligibility.
For more information, please click here.
